FT商学院

Trump’s drug price treatment is harsh but justified
Lex专栏:特朗普重拳出击美国药价是合理之举

The US is the biggest market for prescription drugs, accounting for roughly $600bn of annual sales out of a global $1tn or so
2022年美国药品的名义价格是33个经合组织国家对比组平均水平的2.8倍。

“You get what you pay for” has a nice ring to it. But it does not accurately describe the situation of those buying prescription pharmaceuticals in the US. President Trump, who has vowed to lower drugs prices by as much as 80 per cent, may finally have found a useful target for his sledgehammer. 

“一分钱一分货”这句话说得恰如其分。但这并不能准确描述美国处方药购买者的处境。美国总统特朗普发誓要将药价降低最多80%,他可能终于为他的大锤找到了一个有用的靶子。

您已阅读10%(378字),剩余90%(3547字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×